BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7487311)

  • 1. [Adrenergic betablockers and heart failure].
    Lechat P
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):611-5. PubMed ID: 7487311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Beta-blockers and heart failure].
    Lechat P
    Therapie; 1994; 49(3):219-24. PubMed ID: 7878587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockade treatment in heart failure: the cardiac insufficiency bisoprolol study (CIBIS) project. CIBIS Committees and Investigators. Cardiac Insufficiency Bisoprolol Study.
    Lechat P
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S158-63. PubMed ID: 11534531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of heart failure with beta-blockers?].
    Osterziel KJ; Dietz R
    Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
    Sinagra G; Perkan A; Zecchin M; Di Lenarda A; Lardieri G; Rakar S; Secoli G; Pinamonti B; Camerini F
    G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers in heart failure: how far have we progressed?
    Adams KF
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):7-15. PubMed ID: 19667603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of the cardiac insufficiency bisoprolol study II (CIBIS II). The CIBIS II Scientific Committee.
    Fundam Clin Pharmacol; 1997; 11(2):138-42. PubMed ID: 9107560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker efficacy according to heart rate and rhythm in patients with heart failure. Commentary on the Cardiac Insufficiency Bisoprolol Study II analysis.
    Lechat PP
    Card Electrophysiol Rev; 2003 Sep; 7(3):233-5. PubMed ID: 14739720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: modification by beta receptor blockers--a therapeutic approach?].
    Lohmann FW
    Herz; 1990 Jun; 15(3):202-6. PubMed ID: 1973915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of functional capacity and survival in congestive heart failure. Effects of activation of the sympathetic nervous system.
    Packer M
    Postgrad Med; 1988 Feb; Spec No():96-103. PubMed ID: 2894667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of beta blockers in heart failure: clinical studies].
    Cobelli F
    Ital Heart J Suppl; 2000 Aug; 1(8):996-1002. PubMed ID: 10993005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
    Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
    Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression and beta-blockade in heart failure.
    Lee HR; O'Connell JB; Mason JW
    Cardiol Clin; 1989 Feb; 7(1):171-81. PubMed ID: 2565162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
    Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E
    Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cardiac myopathies with beta blockers. What do we know, where do we go from here?
    Anderson JL
    Postgrad Med; 1988 Feb; Spec No():104-12. PubMed ID: 2894653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
    Deedwania PC; Giles TD; Klibaner M; Ghali JK; Herlitz J; Hildebrandt P; Kjekshus J; Spinar J; Vitovec J; Stanbrook H; Wikstrand J;
    Am Heart J; 2005 Jan; 149(1):159-67. PubMed ID: 15660048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of cardiac insufficiency: does treatment depend on whether its cause is ischemic or idiopathic?].
    Galinier M; Bounhoure JP
    Arch Mal Coeur Vaiss; 1999 Jun; 92(6):727-32. PubMed ID: 10410811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effects of bisoprolol in congestive heart failure due to dilated cardiomyopathy].
    Li Z; Li L
    Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):683-6. PubMed ID: 8731831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.